Correlation Between Qs Global and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qs Global and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qs Global and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qs Global Equity and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Qs Global and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qs Global with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qs Global and Pharmaceuticals Ultrasector.

Diversification Opportunities for Qs Global and Pharmaceuticals Ultrasector

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between SMYIX and Pharmaceuticals is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Qs Global Equity and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Qs Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qs Global Equity are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Qs Global i.e., Qs Global and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Qs Global and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Qs Global Equity is expected to generate 0.54 times more return on investment than Pharmaceuticals Ultrasector. However, Qs Global Equity is 1.86 times less risky than Pharmaceuticals Ultrasector. It trades about 0.08 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.0 per unit of risk. If you would invest  1,840  in Qs Global Equity on April 22, 2025 and sell it today you would earn a total of  844.00  from holding Qs Global Equity or generate 45.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Qs Global Equity  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Qs Global Equity 

Risk-Adjusted Performance

Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Qs Global Equity are ranked lower than 29 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Qs Global showed solid returns over the last few months and may actually be approaching a breakup point.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Qs Global and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qs Global and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Qs Global and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qs Global position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Qs Global Equity and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal